Laboratory research use only. Not for human or animal consumption.

Peptides

View as Grid List
Sort by

NAD+

A cellular cofactor involved in energy metabolism, repair signaling, and oxidative stress response.

EnergyAging
More library details

Research context

  • Supports redox reactions and mitochondrial energy metabolism.
  • Involved in DNA repair and cellular stress pathways.

Review before use

  • Review route, dose, flushing, nausea, and heart rhythm history.
  • Track energy, sleep, headache, and tolerance.

Evidence notes

  • NAD+ is a cellular cofactor studied in redox biology, mitochondrial energy metabolism, and repair signaling.
  • Clinical evidence varies by route, population, and outcome, so claims should stay conservative.

Cautions

  • Discuss active cancer history and complex medication use.
  • Do not assume more is better.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

$45.00

NAD+ + MOTS-c

A cellular-energy stack concept often discussed around mitochondria, fatigue, and exercise adaptation.

EnergyMito
More library details

Research context

  • Pairs a cellular cofactor with mitochondrial signaling review.
  • Often discussed for fatigue, training response, and metabolic health.

Review before use

  • Review heart rhythm history, glucose medications, fatigue diagnosis, and expectations.
  • Introduce variables one at a time when possible.

Evidence notes

  • This stack combines cellular cofactor and mitochondrial-derived peptide concepts around energy and metabolic signaling.
  • Human evidence remains limited compared with established metabolic or fatigue evaluations.

Cautions

  • Stacking can hide side effects or overstate benefits.
  • Fatigue can signal medical problems that need evaluation.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

Call for pricing

PEG-MGF

A mechano-growth-factor related peptide discussed around muscle repair and training adaptation.

MuscleRepair
More library details

Research context

  • Reviewed for muscle repair and growth signaling after mechanical stress.
  • Often discussed in training and bodybuilding contexts.

Review before use

  • Review legality, evidence, cancer risk, and whether injury requires rehab.
  • Track strength, soreness, swelling, and adverse response.

Cautions

  • Not a replacement for progressive training and recovery.
  • Avoid use around unresolved injury without diagnosis.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

$79.00

Retatrutide

A triple receptor agonist research/clinical-trial class item discussed for appetite, body weight, and metabolic effects.

WeightMetabolic
More library details

Research context

  • Targets GLP-1, GIP, and glucagon pathways.
  • Reviewed for strong body-weight and metabolic effects in research contexts.

Review before use

  • Clarify availability, regulatory status, trial data, and medical appropriateness.
  • Track GI tolerance, hydration, weight rate, and strength preservation.

Evidence notes

  • Investigational triple-receptor agonist class item studied for GLP-1, GIP, and glucagon pathway activity.
  • Clinical studies have evaluated effects on body weight, glucose handling, and cardiometabolic markers.

Cautions

  • Not a casual or unsupervised compound.
  • Use legitimate medical channels only.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

Call for pricing

REV3

A triple receptor agonist research/clinical-trial class item discussed for appetite, body weight, and metabolic effects.

WeightMetabolic
More library details

Research context

  • Targets GLP-1, GIP, and glucagon pathways.
  • Reviewed for strong body-weight and metabolic effects in research contexts.

Review before use

  • Clarify availability, regulatory status, trial data, and medical appropriateness.
  • Track GI tolerance, hydration, weight rate, and strength preservation.

Evidence notes

  • Investigational triple-receptor agonist class item studied for GLP-1, GIP, and glucagon pathway activity.
  • Clinical studies have evaluated effects on body weight, glucose handling, and cardiometabolic markers.

Cautions

  • Not a casual or unsupervised compound.
  • Use legitimate medical channels only.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

$38.00

Selank

A nootropic/anxiolytic peptide discussed for calm focus, stress resilience, and cognitive support.

CalmFocus
More library details

Research context

  • Reviewed for neurotransmitter and stress-response modulation.
  • Often discussed for anxiety, focus, and mental performance.

Review before use

  • Review mental health history, medications, and route.
  • Track anxiety, sleep, focus, and irritability.

Evidence notes

  • Research has explored stress-response, anxiolytic, and cognitive-support themes.
  • Human evidence and regulatory status vary by region, so claims should stay conservative.

Cautions

  • Do not replace psychiatric care or prescribed medications.
  • Stop and seek help for severe mood changes or suicidal thoughts.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

$45.00

Semaglutide

A GLP-1 receptor agonist medication class item commonly reviewed for appetite, satiety, and glucose support.

AppetiteGlucose
More library details

Research context

  • Improves satiety signaling and slows gastric emptying.
  • Supports glucose handling and reduced calorie intake in appropriate patients.

Review before use

  • Review prescription status, escalation plan, GI symptoms, gallbladder risk, and protein intake.
  • Track weight, waist, hydration, bowel habits, and strength training.

Evidence notes

  • GLP-1 receptor agonist medication class with clinical-trial evidence for appetite, glucose, and body-weight outcomes.
  • Research and prescribing use should be separated from research-only product discussion.

Cautions

  • Use only through legitimate medical care.
  • Urgent care is needed for severe abdominal pain, persistent vomiting, or dehydration symptoms.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

Call for pricing

Semax

A cognitive peptide discussed for focus, neuroprotection themes, and mental performance.

FocusDrive
More library details

Research context

  • Reviewed for neurotrophic and cognitive-performance signaling.
  • Often discussed for alertness and focus.

Review before use

  • Review blood pressure, anxiety, sleep, stimulant use, and timing.
  • Track focus, irritability, headache, and sleep changes.

Evidence notes

  • Research has explored neurotrophic signaling and cognitive-performance themes.
  • Evidence quality and regulatory status vary, so avoid strong performance claims.

Cautions

  • Avoid stacking with stimulants without professional guidance.
  • Do not use to cover sleep deprivation.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

$45.00

Sermorelin

A GHRH analog used in some clinics for growth-hormone stimulation review.

GHSleep
More library details

Research context

  • Supports endogenous GH signaling rather than replacing GH.
  • Often evaluated through IGF-1 and symptom tracking.

Review before use

  • Review baseline labs, sleep apnea, glucose control, and expected monitoring schedule.
  • Compare with CJC/ipamorelin options with a clinician.

Evidence notes

  • GHRH analog research and clinical use focus on endogenous growth-hormone stimulation under medical review.
  • Monitoring commonly centers on IGF-1, sleep apnea risk, glucose, edema, and expected clinical goals.

Cautions

  • Hormone-axis protocols require medical supervision.
  • Do not use with unexplained symptoms or active malignancy concerns.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

$43.00

SS-31

A mitochondrial-targeted peptide discussed for cardiolipin support and cellular energy research.

MitoRecovery
More library details

Research context

  • Reviewed for mitochondrial membrane and cardiolipin-related support.
  • Often discussed in fatigue, aging, and performance contexts.

Review before use

  • Review clinical status, regulatory availability, and medication interactions.
  • Track fatigue, exercise response, and adverse symptoms.

Evidence notes

  • Mitochondrial-targeted peptide research has explored cardiolipin interaction and cellular-energy support.
  • Clinical research has focused on disease-specific contexts, not casual wellness use.

Cautions

  • Not appropriate as a self-treatment for cardiac or neurologic disease.
  • Use only with qualified medical guidance.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

Call for pricing

TB-500

A mobility and tissue-remodeling peptide often paired with BPC-157 in recovery discussions.

MobilityRepair
More library details

Research context

  • Associated with actin regulation and tissue repair pathways.
  • Often reviewed for broad soft-tissue recovery rather than one local site.

Review before use

  • Review intended duration and whether local injury requires formal treatment.
  • Track swelling, pain, range of motion, and training response.

Evidence notes

  • Thymosin beta-4 research has explored actin regulation, tissue repair, and wound-healing pathways.
  • Human evidence for commercial TB-500 products is limited; product identity and quality matter.

Cautions

  • Quality and identity testing matter.
  • Discuss cancer history, immune conditions, and medication interactions with a clinician.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

$36.00

Thymosin Alpha-1

An immune-modulating peptide discussed for immune resilience and infection-response contexts.

ImmuneRecovery
More library details

Research context

  • Reviewed for T-cell and immune-response modulation.
  • Often discussed in immune support and recovery protocols.

Review before use

  • Review autoimmune disease, immunosuppressants, cancer history, and infection status.
  • Track symptoms and avoid self-treating serious illness.

Evidence notes

  • Research and clinical literature have explored immune-response modulation and T-cell signaling.
  • Risk review should include autoimmune disease, cancer history, infections, and immunosuppressive medications.

Cautions

  • Immune agents can be inappropriate with autoimmune or transplant-related conditions.
  • Seek care for fever, worsening infection, or severe symptoms.

Educational reference only. Not medical advice, dosing guidance, or a treatment claim.

$130.00